ANTIHYPERTENSIVE THERAPY EFFICIENCY OF PATIENTS WITH METABOLIC SYNDROME

The risk factors of cardiovascular disease both separately and in combination, even of low intensity increase the risk of cardiovascular complications development. The arterial tension increase of patients with increased mass index, dislipidemy, insulin resistance and transabdominal visceral adiposopathy and early atherosclerosis in complex de-termine the notion of metabolic syndrome. One or few unfavorable factors determine the group of patients with high and very high risk of cardiovascular accidents. That’s why during the treatment of arterial hypertension of patients with metabolic syndrome it is necessary to use pathogenetically substantiated antihypertensive drugs along with the basic therapy.